Kenmore Podiatry clinic offers the latest technology for the treatment of warts using Microwave Swift Technology. We are also able to offer more traditional wart treatments if more appropriate.
Warts are a common contagious infection in the outer layers of the skin which are caused by HPV (Human Papillomavirus). They can spread to other areas of our body and from person to person. Warts are generally very difficult to get rid of, as they are excellent at evading the body’s immune system.
SWIFT is medical microwave technology that is highly effective at resolving warts, verrucae or papillomas. A focused microwave signal is emitted into the skin to a predetermined depth to ensure only the wart is treated. A process called Heat Shock occurs within infected skin cells. This causes the wart to release certain proteins into the circulatory system, allowing the immune system to recognise the infection and begin to fight the virus.
The rapid heating of the wart to 42-45ºC can cause discomfort, however this lasts for only a second. This temperature range is merely a few degrees warmer than a hot bath and will not cause any serious tissue damage or scarring.
Microwaves are a form of non-ionising radiation, which means that they cannot cause damage to the DNA of living things. SWIFT uses very low energy levels that are only able to vibrate water molecules within skin cells.
The number of treatments is dependent on how you respond to treatment, however most patients require 3 treatments or less. Treatments are performed monthly. Your Podiatrist will be able to discuss your treatment plan.
Most patients are suitable for SWIFT treatment except for those who are pregnant, have a pacemaker or implantable cardioverter defibrillator, or who have metal implants near the lesions being treated. Our expert podiatrists perform a pre-treatment assessment on all patients who are a candidate for SWIFT treatment.
No. One of the great benefits of SWIFT is no down time from sports or daily activities. There is typically no need for dressings or aftercare.
* Based on data collected and analysed from post market surveillance July 2017 of trained SWIFT users.